Chrono Therapeutics Receives $32,000,000 Series A Financing Round

  • Feed Type
  • Date
    6/13/2014
  • Company Name
    Chrono Therapeutics
  • Mailing Address
    1377 Main St. Waltham, MA 02451 USA
  • Company Description
    Chrono Therapeutics (CHRONO) is a pharmaceutical company founded in 2004 with a vision of transforming disease and addiction management to become the market leader in programmable passive transdermal drug delivery (TDD) that offers real-time behavioral support.
  • Website
    http://www.chronothera.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $32,000,000
  • Transaction Round
    Series A
  • Proceeds Purposes
    The company plans to use the funds for that purpose, as well as further product development.
  • M&A Terms
  • Venture Investor
  • Venture Investor
  • Venture Investor
  • Venture Investor
  • Venture Investor

By posting a comment, you agree to our terms and conditions.